Skip to main content.
Menu

Brian Overstreet

Picture of William Heisel

A new company aims to clean up the FDA's messy data for reporting drug adverse events and market it to pharma and other businesses. Health reporters can benefit from the company's work, too.

Picture of William Heisel

Why is the FDA'S adverse events drug database in such a shambles? Scientist Keith Hoffman explains — and talks about how his company has found a business opportunity in that messy data.

Picture of R. Jan Gurley

A new start-up is mining the FDA's adverse event data for medications and finding potentially dangerous patterns that the regulatory agency hasn't addressed — but should.

Announcements

In this webinar, two of the country’s leading health care policy reporters will give fellow reporters a behind-the-scenes look at how they track news developments, ferret out original stories and stay on top of their beat every day. Sign up here!

Want to improve your data journalism skills?  Apply now for the 2018 Data Fellowship -- four all-expenses-paid days of training on data acquisition, analysis and visualization, a $2,000-$4,000  reporting grant and six months of expert mentoring.  Dates:  October 17-20. Deadline: August 27 for California journalists, Sept. 7 for journalists from other states

CONNECT WITH THE COMMUNITY

Member Activities

Sarah Smith commented on a post

Join the conversation.

Martha Rosenberg has shared a blog post

Read it.

Anna Romano has shared a blog post

Read it.

Kellie Schmitt has shared a blog post

Read it.

Robert C. Bowman, M.D. commented on a post

Join the conversation.
More Member Activities